Non-nucleoside inhibitors with higher selectivity and permeability have been developed, such as UZH1a and UZH2.418,419 A novel METTL3 inhibitor STM2457 effectively blocked AML progression and prolonged survival in AML mouse models, without disturbing normal hematopoiesis.420. Here, METTL3 is linked to acute myeloid leukemia.